Drug Shortage Report for ETHACRYNATE SODIUM FOR INJECTION USP

Last updated on 2020-04-07 History
Report ID 94977
Drug Identification Number 02469456
Brand name ETHACRYNATE SODIUM FOR INJECTION USP
Common or Proper name ETHACRYNATE SODIUM FOR INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) ETHACRYNIC ACID
Strength(s) 50MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 VIAL
ATC code C03CC
ATC description HIGH-CEILING DIURETICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-10-15
Actual start date
Estimated end date 2020-04-06
Actual end date 2020-04-06
Shortage status Resolved
Updated date 2020-04-07
Company comments
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-04-07 English Compare
v9 2020-04-06 French Compare
v8 2020-04-06 English Compare
v7 2020-02-05 French Compare
v6 2020-02-05 English Compare
v5 2020-01-28 French Compare
v4 2020-01-28 English Compare
v3 2019-10-16 English Compare
v2 2019-09-27 French Compare
v1 2019-09-27 English Compare